NFE2L2 and cancer: As we recently found that NRF2 promotes the transcriptional upregulation of a similar set of cytokines and chemokines, which we collectively named the NISP [50], we hypothesized that activation of NRF2 by G12Ci may form an integral component of the mechanism through which these drugs promote anti-cancer immunity (FIG. S5B).